GlassScriptPhysician profile
Erin Kimble
NPI 1881147130
$4,900.46
in general payments reported to CMS, 2019-2025
14 companies · $1,560 in 2025
The $1,560 reported for 2025 was more than what 90% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $278 · 2022: $703 · 2023: $1,060 · 2024: $1,300 · 2025: $1,560.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,766 · Education: $154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,765.52 |
| Education | $153.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,642.90 | 2022-2025 | |
| Amgen INC. | $659.72 | 2021-2025 | Tavneos, Evenity, Enbrel |
| Glaxosmithkline, LLC. | $559.55 | 2021-2024 | Benlysta |
| Ucb, INC. | $238.59 | 2021-2025 | Cimzia, Bimzelx |
| Janssen Biotech, INC. | $203.06 | 2022-2025 | Tremfya |
| Genzyme Corporation | $172.91 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $152.30 | 2024-2025 | Orencia |
| Novartis Pharmaceuticals Corporation | $56.60 | 2023-2024 | |
| Genentech USA, INC. | $52.42 | 2025 | Gazyva, Actemra |
| Sobi, INC | $49.33 | 2022-2024 | |
| Pfizer INC. | $39.46 | 2021-2024 | |
| Aurinia Pharma U.S., INC. | $38.44 | 2021-2023 | Lupkynis |
| Radius Health, INC. | $19.95 | 2024 | Tymlos |
| Hikma Pharmaceuticals USA | $15.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Kimble listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.